{"id":"https://openalex.org/W2791194243","doi":"https://doi.org/10.1016/j.neurol.2018.01.212","title":"Proportions de patients atteints d\u2019une forme tr\u00e8s active de SEP r\u00e9currente ne pr\u00e9sentant aucun signe d\u2019activit\u00e9 de la maladie en r\u00e9ponse au traitement par cladribine comprim\u00e9s dans l\u2019\u00e9tude CLARITY","display_name":"Proportions de patients atteints d\u2019une forme tr\u00e8s active de SEP r\u00e9currente ne pr\u00e9sentant aucun signe d\u2019activit\u00e9 de la maladie en r\u00e9ponse au traitement par cladribine comprim\u00e9s dans l\u2019\u00e9tude CLARITY","publication_year":2018,"publication_date":"2018-03-25","ids":{"openalex":"https://openalex.org/W2791194243","doi":"https://doi.org/10.1016/j.neurol.2018.01.212","mag":"2791194243"},"language":"fr","primary_location":{"id":"doi:10.1016/j.neurol.2018.01.212","doi":"https://doi.org/10.1016/j.neurol.2018.01.212","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.neurol.2018.01.212","pdf_url":null,"source":{"id":"https://openalex.org/S124451323","display_name":"Revue Neurologique","issn_l":"0035-3787","issn":["0035-3787","2213-0004"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Revue Neurologique","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5015754502","display_name":"Gavin Giovannoni","orcid":"https://orcid.org/0000-0001-9995-1700","observed_orcids":["https://orcid.org/0000-0001-9995-1700"]},"institutions":[{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Gavin Giovannoni","raw_affiliation_strings":["Neurologie, Queen Mary University of London, Londres, Royaume-Uni"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurologie, Queen Mary University of London, Londres, Royaume-Uni","institution_ids":["https://openalex.org/I166337079"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025462803","display_name":"Patrick Vermersch","orcid":"https://orcid.org/0000-0003-0997-8817","observed_orcids":["https://orcid.org/0000-0003-0997-8817"]},"institutions":[{"id":"https://openalex.org/I3018718406","display_name":"Centre Hospitalier Universitaire de Lille","ror":"https://ror.org/02ppyfa04","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018718406"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Patrick Vermersch","raw_affiliation_strings":["Service de neurologie, CHU de Lille, Lille, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Service de neurologie, CHU de Lille, Lille, France","institution_ids":["https://openalex.org/I3018718406"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010771032","display_name":"Fernando Dangond","orcid":"https://orcid.org/0000-0002-6723-4229","observed_orcids":["https://orcid.org/0000-0002-6723-4229"]},"institutions":[{"id":"https://openalex.org/I4405266695","display_name":"Merck Healthcare KGaA, Darmstadt (Germany)","ror":"https://ror.org/04vpzfb52","country_code":"DE","type":"company","lineage":["https://openalex.org/I164928964","https://openalex.org/I4405266695"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Fernando Dangond","raw_affiliation_strings":["Neurology, EMD Serono Research Center, Billerica, \u00c9tats-Unis"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurology, EMD Serono Research Center, Billerica, \u00c9tats-Unis","institution_ids":["https://openalex.org/I4405266695"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5000898624","display_name":"Christine Hicking","orcid":"https://orcid.org/0009-0002-7750-8892","observed_orcids":["https://orcid.org/0009-0002-7750-8892"]},"institutions":[{"id":"https://openalex.org/I164928964","display_name":"Merck KGaA, Darmstadt (Germany)","ror":"https://ror.org/04b2dty93","country_code":"DE","type":"company","lineage":["https://openalex.org/I164928964"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Christine Hicking","raw_affiliation_strings":["Neurologie, Merck, Darmstadt, Allemagne"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurologie, Merck, Darmstadt, Allemagne","institution_ids":["https://openalex.org/I164928964"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5025462803"],"corresponding_institution_ids":["https://openalex.org/I3018718406"],"apc_list":{"value":3620,"currency":"USD","value_usd":3620},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0243624,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"174","issue":null,"first_page":"S94","last_page":"S94"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11827","display_name":"Polyomavirus and related diseases","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/relapsing-multiple-sclerosis","display_name":"relapsing multiple sclerosis","score":0.8650000095367432},{"id":"https://openalex.org/keywords/cladribine","display_name":"cladribine","score":0.7519999742507935},{"id":"https://openalex.org/keywords/clarity-trial","display_name":"CLARITY trial","score":0.859000027179718},{"id":"https://openalex.org/keywords/no-evidence-of-disease-activity","display_name":"no evidence of disease activity","score":0.9089999794960022},{"id":"https://openalex.org/keywords/relapse-prevention","display_name":"relapse prevention","score":0.6430000066757202},{"id":"https://openalex.org/keywords/gadolinium-enhancing-lesions","display_name":"gadolinium-enhancing lesions","score":0.8090000152587891},{"id":"https://openalex.org/keywords/t2-lesions","display_name":"T2 lesions","score":0.5910000205039978},{"id":"https://openalex.org/keywords/disease-modifying-therapy","display_name":"disease-modifying therapy","score":0.6460000276565552},{"id":"https://openalex.org/keywords/subgroup-analysis","display_name":"subgroup analysis","score":0.6019999980926514},{"id":"https://openalex.org/keywords/treatment-response-prediction","display_name":"treatment response prediction","score":0.4830000102519989},{"id":"https://openalex.org/keywords/mri-lesion-load","display_name":"MRI lesion burden","score":0.4740000069141388},{"id":"https://openalex.org/keywords/treatment-naive-patients","display_name":"treatment-naive patients","score":0.39899998903274536},{"id":"https://openalex.org/keywords/treatment-experienced-patients","display_name":"treatment-experienced patients","score":0.5649999976158142},{"id":"https://openalex.org/keywords/relapse-rate","display_name":"relapse rate","score":0.33000001311302185}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7552957534790039},{"id":"https://openalex.org/C29456083","wikidata":"https://www.wikidata.org/wiki/Q1221899","display_name":"Gynecology","level":1,"score":0.4532720148563385},{"id":"https://openalex.org/C2989005","wikidata":"https://www.wikidata.org/wiki/Q214963","display_name":"Nuclear medicine","level":1,"score":0.3304460942745209}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.neurol.2018.01.212","doi":"https://doi.org/10.1016/j.neurol.2018.01.212","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.neurol.2018.01.212","pdf_url":null,"source":{"id":"https://openalex.org/S124451323","display_name":"Revue Neurologique","issn_l":"0035-3787","issn":["0035-3787","2213-0004"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Revue Neurologique","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2789818810","https://openalex.org/W2593920988","https://openalex.org/W2592679059","https://openalex.org/W3084097024","https://openalex.org/W2925279874","https://openalex.org/W3084339209","https://openalex.org/W4392876028","https://openalex.org/W2592339183","https://openalex.org/W7000253968","https://openalex.org/W2791381998"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2018-03-29T00:00:00"}